Tetrathiomolybdate Partially Alleviates Erectile Dysfunction of Type 1 Diabetic Rats Through Affecting Ceruloplasmin/eNOS and Inhibiting Corporal Fibrosis and Systemic Inflammation

Introduction: Patients with erectile dysfunction induced by diabetes mellitus (DMED) show a poor effect rate for oral phosphodiesterase type 5 inhibitors (PDE5is). Therefore, the new therapeutic strategy is necessary in patients with DMED. Aim: To investigate whether Tetrathiomolybdate (TM) suppleme...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yinghao Yin, MS, Jingxuan Peng, MS, Jun Zhou, MS, Hanfei Chen, MS, Dongyi Peng, PhD, Dongjie Li, PhD, Yu Gan, PhD, Guangming Yin, PhD, Yuxin Tang, PhD
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2022
Materias:	Tetrathiomolybdate Diabetes Mellitus Erectile Dysfunction Ceruloplasmin eNOS Medicine R Other systems of medicine RZ201-999
Acceso en línea:	https://doaj.org/article/288fc032c5c945c9aee31c19a0d4e9af
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Tetrathiomolybdate Partially Alleviates Erectile Dysfunction of Type 1 Diabetic Rats Through Affecting Ceruloplasmin/eNOS and Inhibiting Corporal Fibrosis and Systemic Inflammation

Ejemplares similares